| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.007 |